Monday 24 November 2014

Merck buys rights to NewLink's experimental Ebola vaccine

(Reuters) - Merck & Co Inc will buy worldwide commercial rights to NewLink Genetics Corp's experimental Ebola vaccine.


via Reuters: Health News Read More Here..

No comments:

Post a Comment